JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

Search

Globus Medical Inc (Class A)

Atvērts

SektorsVeselības aprūpe

62.82 0.59

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

61.65

Max

62.98

Galvenie mērījumi

By Trading Economics

Ienākumi

127M

203M

Pārdošana

147M

745M

P/E

Sektora vidējais

23.064

37.461

Peļņas marža

27.215

Darbinieki

5,300

EBITDA

29M

193M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+30.99% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 6. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

786M

8B

Iepriekšējā atvēršanas cena

62.23

Iepriekšējā slēgšanas cena

62.82

Ziņu noskaņojums

By Acuity

50%

50%

163 / 371 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bullish Evidence

Globus Medical Inc (Class A) Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 23. okt. 20:49 UTC

Peļņas

Correction to Thermo Fisher Article on Oct. 22

2025. g. 23. okt. 23:51 UTC

Tirgus saruna

WiseTech Bull Cheered by DSV's Freight Volumes -- Market Talk

2025. g. 23. okt. 23:49 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 23. okt. 23:49 UTC

Tirgus saruna

Nikkei May Rise on Hopes for Easing U.S.-China Tensions -- Market Talk

2025. g. 23. okt. 23:37 UTC

Tirgus saruna

Gold Falls on Likely Further Unwinding of Long Positions -- Market Talk

2025. g. 23. okt. 22:58 UTC

Tirgus saruna

Global Energy Roundup: Market Talk

2025. g. 23. okt. 22:57 UTC

Tirgus saruna

Woodside's Deal With Williams Eases Risks on Louisiana LNG Project -- Market Talk

2025. g. 23. okt. 22:49 UTC

Iegādes, apvienošanās, pārņemšana

How Trump Sparked a New Era of State Capitalism -2-

2025. g. 23. okt. 22:49 UTC

Iegādes, apvienošanās, pārņemšana

How Trump Sparked a New Era of State Capitalism -- Barrons.com

2025. g. 23. okt. 22:17 UTC

Peļņas

Intel Shows Progress in First Earnings Report Since U.S. Investment -- 3rd Update

2025. g. 23. okt. 21:41 UTC

Peļņas

Intel Shows Progress in First Earnings Report Since U.S. Investment -- 2nd Update

2025. g. 23. okt. 21:05 UTC

Peļņas

Valero Earnings Show Why Refiners Are Energy's Big Winners This Year -- Barrons.com

2025. g. 23. okt. 20:50 UTC

Tirgus saruna
Peļņas

Tech, Media & Telecom Roundup: Market Talk

2025. g. 23. okt. 20:50 UTC

Tirgus saruna
Peļņas

Auto & Transport Roundup: Market Talk

2025. g. 23. okt. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 23. okt. 20:35 UTC

Peļņas

These Stocks Moved the Most Today: Tesla, IBM, D-Wave Quantum, Dow Inc., Molina Healthcare, Las Vegas Sands, Southwest, and More -- Barrons.com

2025. g. 23. okt. 20:28 UTC

Peļņas

Intel Shows Progress in First Earnings Report Since U.S. Investment -- Update

2025. g. 23. okt. 20:15 UTC

Tirgus saruna
Peļņas

Global Commodities Roundup: Market Talk

2025. g. 23. okt. 20:10 UTC

Peļņas

Newmont Mining 3Q Adj EPS $1.71

2025. g. 23. okt. 20:10 UTC

Peļņas

Newmont Mining 3Q Sales $5.52B

2025. g. 23. okt. 20:10 UTC

Peļņas

Newmont Mining 3Q EPS $1.67

2025. g. 23. okt. 20:09 UTC

Peļņas

Intel Stock Rises After Strong Earnings. CFO Says Chip Demand Will Outpace Supply Into Next Year. -- Barrons.com

2025. g. 23. okt. 20:07 UTC

Tirgus saruna
Peļņas

Global Equities Roundup: Market Talk

2025. g. 23. okt. 20:07 UTC

Tirgus saruna
Peļņas

Ford Scrambles to Mitigate New Costs from Supplier Fire -- Market Talk

2025. g. 23. okt. 20:07 UTC

Peļņas

Blackstone Looks to IPOs for Investment Exits -- Update

2025. g. 23. okt. 20:05 UTC

Peļņas

Intel 3Q Gross Margin 38.2% >INTC

2025. g. 23. okt. 20:04 UTC

Peļņas

Intel CFO: 'Current Demand Is Outpacing Supply, a Trend We Expect Will Persist Into 2026' >INTC

2025. g. 23. okt. 20:04 UTC

Peļņas

Intel Shows Progress in First Earnings Report Since U.S. Investment -- WSJ

2025. g. 23. okt. 20:04 UTC

Peļņas

Intel: 4Q Guidance Excludes Altera >INTC

2025. g. 23. okt. 20:04 UTC

Peļņas

Intel Sees 4Q Adj EPS 8c >INTC

Salīdzinājums

Cenas izmaiņa

Globus Medical Inc (Class A) Prognoze

Cenas mērķis

By TipRanks

30.99% augšup

Prognoze 12 mēnešiem

Vidējais 81.67 USD  30.99%

Augstākais 106 USD

Zemākais 65 USD

Pamatojoties uz 11 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Globus Medical Inc (Class A) — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

11 ratings

7

Pirkt

4

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

72.18 / 73.07Atbalsts un pretestība

Īstermiņā

Bullish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Weak Bearish Evidence

Noskaņojums

By Acuity

163 / 371 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat